2025-07-29 - Analysis Report
Okay, here's an analysis of Eli Lilly and Co (LLY) based on the provided data, formatted for a concise English report with key figures and insights.

## Eli Lilly and Co (LLY) Stock Analysis

**Company Overview:** Eli Lilly and Co is a global pharmaceutical company that discovers, develops, manufactures, and markets pharmaceutical products.

**1. Performance vs. S&P 500 (VOO)**

*   **Ticker:** LLY
*   **Cumulative Return (LLY):** 247.29%
*   **Cumulative Return (VOO):** 99.63%
*   **Absolute Spread:** 147.66% (LLY outperformed VOO by this margin)
*   **Spread Range:** Max: 311.6, Min: -27.3
*   **Relative Spread:** 52.2 (LLY's outperformance is positioned in the upper-mid range of its historical spread against the S&P 500).

**Alpha, Beta Analysis:**

| Year      | CAGR   | MDD   | Alpha  | Beta  | Cap(B) |
| :---------- | :----- | :----- | :------ | :----- | :------ |
| 2015-2017 | 10.0% | 56.3% | -19.0% | 0.0  | 75.8   |
| 2016-2018 | 39.0% | 58.6% | 21.0%  | -0.1 | 103.9  |
| 2017-2019 | 50.0% | 58.6% | 20.0%  | 0.3  | 118.0  |
| 2018-2020 | 52.0% | 58.6% | 33.0%  | 0.1  | 151.6  |
| 2019-2021 | 106.0% | 60.6% | 57.0%  | 0.2  | 248.0  |
| 2020-2022 | 98.0% | 64.8% | 96.0%  | 0.2  | 328.4  |
| 2021-2023 | 133.0% | 64.8% | 115.0% | 0.3  | 523.3  |
| 2022-2024 | 150.0% | 72.2% | 124.0% | 0.2  | 693.0  |
| 2023-2025 | 100.0% | 76.8% | 49.0%  | 0.2  | 725.5  |

**Analysis:**

*   LLY has significantly outperformed the S&P 500. The relative spread suggests this outperformance is historically strong but not at its absolute peak.
*   Alpha is overwhelmingly positive, showing consistent returns above the market, implying a degree of independent value generation.
*   Beta has generally been low (around 0.2), indicating that LLY's price is not strongly correlated with overall market movements.
*   CAGR is excellent, but MDD is substantial, so LLY could be a risky investment.
*   Market Capitalization has also increased greatly over time.

**2. Recent Stock Price Movement**

*   **Current Price:** 808.11
*   **Previous Close:** 812.69
*   **Change:** -0.56
*   **5-Day Moving Average:** 800.31
*   **20-Day Moving Average:** 784.84
*   **60-Day Moving Average:** 772.01

**Analysis:** The price has dipped slightly. The 5-day moving average is above the 20-day and 60-day averages, suggesting a short-term upward trend. The price being above all moving averages confirms an overall upward trajectory.

**3. Market Risk Indicators & Expected Return**

*   **Market Risk Indicator (MRI):** 0.33 (Low Risk)
*   **RSI:** 58.93 (Neutral)
*   **PPO:** 0.40 (Neutral)
*   **Hybrid Signal:** Cash 0%, Buy 90% of cash (7 shares - Safe - MRI:0.33)
*   **Delta_Previous_Relative_Divergence:** -0.3 (Short-term decrease)
*   **Expected Return:** 149.0% (Long-term, vs. S&P 500)

**Analysis:** The MRI indicates low market risk.  The RSI and PPO are neutral. The negative delta relative divergence suggests some short-term downward pressure. The significant expected return suggests a highly optimistic outlook for long-term investors.

**4. Recent News & Significant Events**

*   **2025-07-26:** Major business developments, regulatory changes, or market events.
*   **2025-07-29:** Analyst discussions regarding performance and outlook.
*   **2025-07-25:** Stock volatility influenced by recent news/earnings.
*   **2025-07-28:** Market experts highlighting risks and opportunities.

**Analysis:** Recent news suggests significant activity affecting LLY's stock, including market volatility and analyst attention.

**5. Recent Earnings Analysis**

| Date       | EPS  | Revenue      |
| :----------- | :----- | :------------- |
| 2025-05-01 | 3.07 | 12.73 B$       |
| 2024-10-30 | 1.08 | 11.44 B$       |
| 2024-08-08 | 3.29 | 11.30 B$       |
| 2024-04-30 | 2.49 | 8.77 B$        |
| 2025-05-01 | 2.49 | 8.77 B$        |

**Analysis:** EPS and revenue show volatility, which may be due to the impact of seasonality, production cycle, or external factors such as economy and demand.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue    | Profit Margin |
| :--------- | :--------- | :-------------- |
| 2025-03-31 | $12.73B | 82.53%        |
| 2024-12-31 | $13.53B | 82.24%        |
| 2024-09-30 | $11.44B | 81.02%        |
| 2024-06-30 | $11.30B | 80.80%        |
| 2024-03-31 | $8.77B  | 80.91%        |

**Capital and Profitability:**

| Quarter    | Equity      | ROE       |
| :--------- | :---------- | :-------- |
| 2025-03-31 | $15.76B  | 17.50%   |
| 2024-12-31 | $14.19B  | 31.07%   |
| 2024-09-30 | $14.24B  | 6.81%    |
| 2024-06-30 | $13.56B  | 21.88%   |
| 2024-03-31 | $12.81B  | 17.51%   |

**Analysis:** Revenue has generally increased, and profit margins remain high, indicating good operational efficiency.  ROE fluctuates, so it may be necessary to consider cash flow or other financial data to get the right investment direction.

**7. Overall Summary**

LLY has shown remarkable outperformance compared to the S&P 500, driven by high alpha generation. Recent news indicates significant activity and volatility in the stock. Financial data reveals rising revenue and high-profit margins, but ROE is variable. While short-term indicators suggest a slight dip, the long-term expected return is very optimistic. Investors should carefully monitor recent news, earnings reports, and industry trends to make informed decisions.
